Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma (vol 10, e004291, 2022)

被引：0
|
作者：
Liu, J.
Yang, Y.
Liu, Z.
机构：
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷 / 06期
关键词：
D O I：
10.1136/jitc-2021-004291corr1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
    Chengzhi Ding
    Yijun Guo
    Yaning zhou
    Yi He
    Chunji Chen
    Ming Zhang
    Xufeng Guo
    BMC Cancer, 23
  • [42] Neoadjuvant sintilimab and chemotherapy in patients with resectable esophageal squamous cell carcinoma: A prospective, single-arm, phase 2 trial
    Zhang, Zhi
    Ye, Jinjun
    Li, Hui
    Gu, Dayong
    Du, Mingyu
    Ai, Dashan
    Chen, Wei
    Fang, Ying
    Xu, Xinyu
    Bai, Chenguang
    Zhao, Kuaile
    Zhou, Guoren
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [43] Neoadjuvant Nivolumab Therapy for Esophageal Squamous Cell Carcinoma: A Single-Arm, Phase II Study
    Park, Sehhoon
    Lee, Yurimi
    Lee, Jiyun
    Min, Yang Won
    Kim, Hong Kwan
    Chol, Joon Young
    Jung, Hyun Ae
    Choi, Yong Soo
    Choi, Yoon-La
    Shim, Young Mog
    Sun, Jong-Mu
    CANCER RESEARCH AND TREATMENT, 2024, 56 (02): : 567 - 579
  • [44] Neoadjuvant chemoimmunotherapy for the treatment of locally advanced laryngeal and hypopharyngeal squamous cell carcinoma: A single-arm phase 2 clinical trial.
    Chen, Yanfeng
    Yang, Ankui
    Mao, Yan-Ping
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] Scientific Plenary Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI Study): A prospective, single-arm, phase II trial
    Hu, Yingjie
    Chen, Jing
    Shen, Yuanming
    Wang, Yanzhou
    Song, Kun
    Xia, Bairong
    Chen, Xiaojun
    Zou, Dongling
    Wang, Yingmei
    Chen, Gang
    Sun, Chaoyang
    Ma, Ding
    Li, Kezhen
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S13 - S14
  • [46] Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI Study): a study protocol of a prospective, single-arm, phase II trial
    Chen, Jing
    Han, Yingyan
    Hu, Yingjie
    Feng, Xue
    Meng, Xiaolin
    Guo, Shuaiqingying
    Sun, Chaoyang
    Chen, Gang
    Li, Kezhen
    BMJ OPEN, 2023, 13 (05):
  • [47] Tislelizumab plus chemotherapy as induction treatment followed by chemoradiotherapy or surgery in locally advanced hypopharyngeal squamous cell carcinoma: A single-arm, phase II trial
    Gui, Lin
    Liu, Shaoyan
    Wang, Xiaolei
    Zhang, Ye
    He, Xiaohui
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] Inductive camrelizumab and apatinib for patients with locally advanced and resectable oral squamous cell carcinoma: A single-arm trial (Icemelting trial).
    Zhong, Lai-Ping
    Ju, Wu-tong
    Xia, Rong-hui
    Zhu, Qi
    Zhu, Guopei
    Dou, Shengjin
    Li, Jiang
    Dong, Min-jun
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [49] Neoadjuvant camrelizumab and chemotherapy in patients with resectable esophageal squamous cell carcinoma: A prospective, single-arm, open-label study
    Wang, Jianping
    Zhang, Jian
    Gao, Jie
    Zhao, Mengmeng
    Ma, Zhenkai
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 33 (06): : 573 - 581
  • [50] Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial
    Li, Kezhen
    Chen, Jing
    Hu, Yingjie
    Wang, Yan-Zhou
    Shen, Yuanming
    Chen, Gang
    Peng, Wenju
    Fang, Zixuan
    Xia, Bairong
    Chen, Xiaojun
    Song, Kun
    Wang, Yingmei
    Zou, Dongling
    Wang, Yan-Chun
    Han, Yingyan
    Feng, Xue
    Yuan, Jing
    Guo, Shuaiqingying
    Meng, Xiaolin
    Feng, Chenzhao
    Chen, Yin
    Yang, Jie
    Fan, Junpeng
    Wang, Jianliu
    Ai, Jihui
    Ma, Ding
    Sun, Chaoyang
    LANCET ONCOLOGY, 2024, 25 (01): : 76 - 85
12345